NY Monthly Puff: 24 New Licenses Approved, Medical Rules Expand, Etain Deal Signed
New York cannabis retail July 2026 brought a busy month across licensing, M&A, and enforcement. The Cannabis Control Board approved 24 more adult-use licenses and adopted updated Part 113 medical regulations, while FLUENT signed a deal to sell its Etain Registered Organization license pending state approval, and OCM executed three search warrants in Niagara Falls. Concentrate share also remains well behind mature markets, pointing to a category with room to grow.
Take a look at the New York retail acquisition opportunities at the bottom of this message.
Top Headlines This Month
- FLUENT signs deal to sell Etain license, pending CCB sign-off
- OCM shuts down pot sales from three vacant Niagara Falls houses
- Concentrates just 3.3% of New York legal sales
- CCB approves 24 licenses, expands medical program
New York: FLUENT Signs Definitive Agreement to Sell Etain LLC Registered Organization License, Pending CCB Approval
FLUENT Corp. entered into a definitive purchase agreement on July 22, 2026 to sell Etain, LLC, its New York operating entity, to an undisclosed third-party operator. The transaction covers Etain’s Registered Organization license, certain New York operating assets, and associated leases, all for cash consideration subject to customary purchase price adjustments. No purchase price was disclosed. FLUENT expects the sale to support the satisfaction of regulatory requirements tied to its previously announced plan of arrangement involving Vireo Growth Inc.
Closing requires approval of the change of ownership by the New York State Cannabis Control Board, along with satisfaction of all conditions precedent to the Vireo arrangement, and the sale has not yet closed. Registered Organization licenses are a limited class within New York’s cannabis framework, so any transfer requires CCB review before it becomes effective. The deal puts that license on a path to new hands while FLUENT works through its broader arrangement with Vireo Growth, and the CCB approval process will set the timeline for when that transition actually completes.
Niagara Falls: OCM Shuts Down Illicit Cannabis Sales at Three Vacant Houses
On July 22, 2026, investigators from the New York State Office of Cannabis Management and detectives from the Niagara Falls Police Narcotics & Intelligence Division executed three search warrants targeting illicit cannabis operations in Niagara Falls, following undercover buys made by the Niagara County Drug Task Force. The warrants covered addresses at 435 20th Street, 1840 Michigan Avenue, and 1643 Weston Avenue, and detectives seized an average of 5.5 pounds of illicit cannabis from each location.
Dan Haughney, OCM’s Director of Enforcement and Investigations, called the seizures significant and noted that no one was living in the homes, which were being used solely for illicit cannabis sales. No arrests were made as a result of the raids, and the residences were later condemned by Falls building inspectors. The multi-agency action reflects OCM’s enforcement presence in upstate New York cannabis market, and pairing warrant execution with property condemnation goes beyond product seizure by removing the physical locations from operation entirely.
New York: Concentrate Sales Trail Mature Markets as Consumer Education Gap Persists
Cannabis concentrates account for just 3.3% of legal cannabis sales in New York, according to a June 2026 commercial report from cannabis education company Higher Function and market intelligence platform Lit Alerts, with the figure measured year to date as of June 19, 2026. New Jersey’s comparable share is 3.7%, and both trail the more than 10% seen in mature markets including Washington, Colorado, Oregon, and Arizona. Higher Function’s research drew on more than 500 consumer surveys and found the biggest barrier to adoption is knowledge, not potency or price, with many consumers saying they did not understand what concentrates are, how to consume them, or how to evaluate product quality.
One New Jersey retailer offers a case study in closing that gap: Baked by the River saw its concentrate sales share grow from 2.5% in 2025 to 5% in 2026, a doubling the retailer credits largely to budtender training and making conversations with customers more approachable. Rick Bashkoff, CEO of Lit Alerts, projects that New York and New Jersey could pick up 1 to 3 percentage points of concentrate market share over the next 12 to 24 months as more connoisseur users transition from the illicit market to the legal market. Concentrates carry premium price points and are associated with larger average basket sizes, so the category’s trajectory in New York will have a meaningful effect on per-store revenue as the market continues to mature.
New York: Cannabis Control Board Approves 24 New Licenses and Updates Medical Regulations
The New York State Cannabis Control Board, at its July 2, 2026 meeting, approved 24 new adult-use cannabis licenses, bringing the statewide total to 2,296 licenses issued. The new approvals broke down as 15 cultivator licenses, 6 processor licenses, 2 retail dispensary licenses, and 1 conditional retail dispensary license, alongside 76 adult-use renewals, 15 CAURD renewals, 36 amendments, and 2 denials. The Board also voted to adopt updated Part 113 regulations for the Medical Cannabis Program, following a public comment period that closed May 25, 2026. Those regulations extend patient certifications from one year to up to two years, raise possession limits to a 60-day supply or up to three ounces of cannabis and 24 grams of concentrate (whichever is greater), and allow qualifying out-of-state medical patients to purchase from Registered Organization dispensing facilities in New York, taking effect upon publication of a Notice of Adoption in the New York State Register.
New York’s combined adult-use and medical retail market reached approximately $895.4 million in year-to-date sales through June 2026, with average daily sales in June reaching approximately $5.26 million, and there are currently 683 legal dispensaries open statewide. On the equity side, 74 percent of licenses approved at the July 2 meeting went to Social and Economic Equity owned businesses, including Community Disproportionately Impacted, minority-owned, and women-owned businesses across cultivation, processing, and retail. Across all adult-use licenses issued to date, 56 percent have gone to SEE applicants. The next Cannabis Control Board meeting is scheduled for August 6, 2026 in Manhattan.
New York Retail Deals
Brooklyn, NY — Park Slope (4th Ave)
Asking: $3,000,000
- Open just over 12 months, generating $2.6M in gross revenue with increasing month-over-month sales
- $850K in net profit over the last 12 months
- 2,000 SF space on a 10+ year lease at $25,750/mo with 25,000 daily traffic count
- Strong unit economics with revenue and profitability trajectory heading in the right direction
Albany, NY — Downtown
Asking: $2,400,000
- Open and operating, 11 months in business with run rate revenue of $115K/mo and growing
- Brand new Class A 1,700 SF buildout with an 11-car lot and drive-thru infrastructure ready to activate
- No other dispensaries within half a mile, only 3 within a mile with significant market whitespace
- 46% gross margin, ~$160K net income across operating period with material EBITDA upside post-close
- Absentee owned, 14-year NNN lease at $5,300/mo with strong upside for an owner-operator
Brooklyn, NY — Manhattan Ave Corridor
Asking: $2,750,000
- Fully licensed, cash-flowing dispensary generating $2.5M to $3M annually with $25K to $35K in monthly free cash flow
- 150+ customers per day on one of Brooklyn’s fastest growing retail corridors with direct subway access
- One of NYC’s only dispensary sites with an adjoining licensed social consumption lounge opportunity
- 3,525 SF total across ground-floor retail, 1,000 SF lounge-ready space, and finished basement
- Full financials and lease available under executed NDA
Staten Island, NY — Port Richmond
Asking: $850,000
- Pre-opening dispensary delivered turnkey and ready to operate at closing
- Seller owns the real estate and is open to leasing or selling the property
- 1,200 to 1,300 SF ground floor plus full basement, street parking and a lot directly across the street
- Lease at $8,000 to $9,000/mo, 6 to 8 weeks from opening
The Bottom Line
New York’s cannabis market moved on multiple fronts in July 2026, with the CCB clearing 24 more licenses and expanding medical patient access, FLUENT setting up an Etain license transfer that still needs state sign-off, and OCM tightening enforcement upstate. The New York cannabis retail July 2026 story is one of a maturing market still working through license transitions, category education, and illicit competition.
📬 Get Monthly Market Updates
Stay ahead of the curve with our monthly cannabis retail market newsletter. New markets, regulatory changes, and expansion opportunities delivered to your inbox.
